3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Graft vs Host Disease
1
Burkitt Lymphoma
1
Blast Crisis
1
Anemia, Aplastic
1
Anemia
1
Interventions
fludarabine phosphate
10
Whole-Body Irradiation
8
Peripheral Blood Stem Cell Transplantation
8
Cyclophosphamide
8
Busulfan
8
Mycophenolic Acid
7
Tacrolimus
6
Antilymphocyte Serum
6
Methotrexate
5
Cyclosporine
5
Melphalan
4
Etoposide
4
thymoglobulin
3
Sirolimus
3
Rituximab
3
Radiotherapy
3
Cord Blood Stem Cell Transplantation
3
fludarabine
2
Ondansetron
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Cyclosporins
2
Carmustine
2
Calcium Dobesilate
2
Aprepitant
2
rasburicase
1
etoposide phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pdgfra-Associated Chronic Eosinophilic Leukemia
×
Immunosuppression Therapy
×
Clear all
No trials found.